Chromadex Liabilities 2024

Chromadex Liabilities

26.51 M USD

Chromadex Dividend yield

Ticker

CDXC

ISIN

US1710774076

WKN

A2AG5N

In 2024, Chromadex's total liabilities amounted to 26.51 M USD, a 4.4% difference from the 25.39 M USD total liabilities in the previous year.

Chromadex Aktienanalyse

What does Chromadex do?

The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Chromadex's Liabilities

Chromadex's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Chromadex's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Chromadex's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Chromadex's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Chromadex’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Chromadex Stock

What is the level of liabilities of Chromadex this year?

Chromadex has a debt balance of 26.51 M USD this year.

What were the liabilities of Chromadex compared to the previous year?

The liabilities of Chromadex have increased by 4.4% increased compared to the previous year.

What are the consequences of high debt for investors of Chromadex?

High liabilities can pose a risk for investors of Chromadex, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Chromadex?

Low liabilities mean that Chromadex has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Chromadex affect the company?

An increase in liabilities of Chromadex can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Chromadex affect the company?

A decrease in the liabilities of Chromadex can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Chromadex?

Some factors that can influence the liabilities of Chromadex include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Chromadex so important for investors?

The liabilities of Chromadex are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Chromadex take to modify the liabilities?

To change its liabilities, Chromadex can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Chromadex pay?

Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.

What is the dividend yield of Chromadex?

The current dividend yield of Chromadex is .

When does Chromadex pay dividends?

Chromadex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chromadex?

Chromadex paid dividends every year for the past 0 years.

What is the dividend of Chromadex?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chromadex located?

Chromadex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chromadex from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Chromadex pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Chromadex in the year 2023?

In the year 2023, Chromadex distributed 0 USD as dividends.

In which currency does Chromadex pay out the dividend?

The dividends of Chromadex are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Chromadex stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Chromadex

Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.